Last week, 246 members of the House of Representatives, including 35 from California, signed a letter to Health and Human Services Secretary Azar urging him to use his authority to address recent actions taken by pharmaceutical companies that undermine the 340B Drug Pricing Program.
Specifically, the letter highlights actions from several pharmaceutical companies that are in violation of statutory requirements, including those that require drug companies to charge no more than the 340B ceiling price when selling their products to 340B providers, as well as demands for extensive claims data that go beyond the scope of the 340B program. CHA supported the letter and thanks members of the California delegation who signed it.
The 35 California representatives who signed the letter are:
- Pete Aguilar – 31st District
- Nanette Barragan – 44th District
- Ken Calvert –- 42nd District
- Tony Cardenas –- 29th District
- Judy Chu – 27th District
- Gilbert Ray Cisneros – 39th District
- Paul Cook – 8th District
- J. Luis Correa –- 46th District
- Jim Costa – 16th District
- TJ Cox – 21st District
- Susan Davis – 53rd District
- Mark DeSaulnier – 11th District
- John Garamendi – 3rd District
- Jimmy Gomez – 34th District
- Ro Khanna – 17th District
- Barbara Lee – 13th District
- Mike Levin – 49th District
- Ted Lieu – 33rd District
- Zoe Lofgren – 19th District
- Alan Lowenthal – 47th District
- Doris O. Matsui – 6th District
- Jerry McNerney – 9th District
- Grace Napolitano – 32d District
- Jimmy Panetta – 20th District
- Katie Porter – 45th District
- Lucille Roybal-Allard – 40th District
- Harley Rouda – 48th District
- Raul Ruiz – 36th District
- Linda Sanchez – 38th District
- Adam Schiff – 28th District
- Brad Sherman – 30th District
- Eric Swalwell – 15th District
- Mike Thompson – 5th District
- Norma Torres – 35th District
- Juan Vargas – 51st District